Andere Sprachen hVIVO plc

Aktien

Verzögert London S.E. Andere Börsenplätze			% 5 Tage	% 1. Jan.
- ^GBX	-.--%		+18.92%	+41.94%

14.02.	Hvivo schließt Sekundärplatzierung ab	MT
14.02.	Hvivo-Aktionäre planen Sekundärplatzierung zum Verkauf von 14 Millionen Aktien	MT

HVIVO achieves record revenue and initiates dividend policy following successful year	09.04.
HVIVO chairman Cathal Friel says he remains committed to hVIVO following share sale	20.02.
Hvivo Completes Secondary Placing	14.02.
Hvivo Shareholders Plan Secondary Placing to Sell 14 Million Shares	14.02.
HVIVO secures Ã‚£6.3 million challenge contract	02.01.
Hvivo Wins GBP6 Million Antiviral Testing Contract	02.01.
Hvivo Secures GBP17 Million Contract for RSV Antiviral Drug Testing; Stock Surges	13.12.
HVIVO secures fresh contract to round out "wonderful" year	13.12.
HVIVO has "the perfect opportunity" after strong first half	12.09.23
Earnings Flash (HVO.L) HVIVO Reports H1 Revenue GBP27.3M	12.09.23
Earnings Flash (HVO.L) HVIVO Posts H1 EPS GBX0.58	12.09.23
HVIVO Limited Reports Earnings Results for the Half Year Ended June 30, 2023	12.09.23
HVIVO Canary Wharf move to deliver material increase in capacity - Proactive Research Analyst	05.09.23
HVIVO announces move to "good facility at a very good price"	31.08.23
Lab Services Company Hvivo to Build New London Facility	29.08.23
HVIVO plc Plans for A New Facility to Meet Growing Demand	29.08.23
HVIVO CEO reports on "very strong" H1 2023	27.07.23
Hvivo Wins GBP13 Million Contract from Global Pharma Client	25.07.23
HVIVO signs second bespoke human challenge model contract in as many months	25.07.23
HVIVO to develop first commercial hMPV human challenge model	28.06.23

Keine Ergebnisse zu dieser Suche